Zum Hauptinhalt springen

Isothiazolinones in commercial products at Danish workplaces

FRIIS, Ulrik Fischer ; MENNE, Torkil ; et al.
In: Contact dermatitis, Jg. 71 (2014), Heft 2, S. 65-74
Online academicJournal - print, 62 ref

Isothiazolinones in commercial products at Danish workplaces. 

Summary: Background: In recent years, a steep increase in the frequency of occupational contact allergy to isothiazolinones has been reported from several European countries. Objective: To examine the extent and occurrence of isothiazolinones in different types of product at Danish workplaces. Methods: Seven different isothiazolinones were identified in the Dictionary ofContactAllergens:ChemicalStructures,Sources, andReferences from Kanerva'sOccupationalDermatitis. By use of the chemical names and Chemical Abstracts Service numbers for these chemicals, information on products registered in the Danish Product Register Database (PROBAS) was obtained. Results: All seven isothiazolinones were registered in PROBAS. The top three isothiazolinones registered were: benzisothiazolinone (BIT), registered in 985 products, methylisothiazolinone (MI), registered in 884 products, and methylchloroisothiazolinone (MCI)/MI, registered in 611 products. The concentration ranges were 0.01 ppm to 45% for BIT, 0.01 ppm to 10% for MI, and 0.01 ppm to 14.1% for MCI/MI. The most common product type was ‘paint and varnish’; five of the seven isothiazolinones were registered in this type of product. Conclusion: Isothiazolinones are present in multiple products registered for use at workplaces, and may occur in high concentrations.

2 ‐ methyl ‐ 4,5 ‐ trimethylene ‐ 4 ‐ isothiazolin ‐ 3 ‐ one; allergic contact dermatitis; benzisothiazolinone; dichlorooctylisothiazolinone; isothiazolinones; methylchloroisothiazolinone; methylisothiazolinone; octylisothiazolinone

Knowledge regarding the individual and general exposures to hazardous chemicals in our environment is pivotal for understanding the individual and general disease risk related to these chemicals. Such information is also essential for the planning of preventive initiatives. Information on the production and use of the chemicals may be retrieved from national and international statistical offices, databases, and manufacturers; this data collection is difficult and time ‐ consuming. The Scandinavian countries have developed registers that contain information on the contents of hazardous chemicals in products registered for occupational use in the respective countries.

The isothiazolinones are preservatives (Table [NaN] ) that have been in use for > 30 years in products for both occupational and consumer use [1] . This group of chemicals was soon recognized as containing strong or extremely potent allergens [2] . Nevertheless, these chemicals were permitted (Table [NaN] ), and registered in different product categories [3] . The general argument made in risk assessment has been that even extremely potent contact allergens can be used safely in products if the exposure concentration is sufficiently low [4] . The risk assessment methods rest primarily on animal assays such as the guinea ‐ pig maximization test (GPMT) [5] or the local lymph node assay (LLNA) [6] ,[7] , and/or experimental induction studies in humans (human repeated insult patch test) [8] . However, these methods have either failed or been incorrectly interpreted with regard to fulfilling the expectations of safety in terms of the risks of sensitization [1] ,[6] ,[7] ,[9] ,[10] . The consequences have been serious, and have given rise to numerous occupational cases of severe allergic contact dermatitis [11] ,[12] ,[13] ,[14] ,[15] ,[16] ,[17] and an epidemic of contact allergy resulting from the use of cosmetic products caused by methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) [1] ,[18] ,[19] ,[20] ,[21] .

Marketed isothaizolinones and their regulation

Isothiazolinones

CAS numbers

Regulations

Cosmetics

REACH

CLP

BPR

Benzisothiazolinone (INCI) (1,2 ‐ benzisothiazolin ‐ 3 ‐ one)

2634 ‐ 33 ‐ 5

Not allowed 22,23

Intended but not registered 24

Harmonized classification: R43/H317 with specific concentration limit: 0.05% 25

Review programme: PT 2, 6, 9, 11, 12, and 13 26

Non ‐ included: PT 7, 10, and 22 27

4,5 ‐ Dichloro ‐ 2 ‐ n ‐ octyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one

64359 ‐ 81 ‐ 5

Not allowed 23

Intended but not registered 24

Not classified

Approved: PT 8

Review programme: PT 7, 9, 10 11, and 21 26

Non ‐ included: PT 6, and 12 27

2 ‐ Methyl ‐ 4,5 ‐ trimethylene ‐ 4 ‐ isothiazolin ‐ 3 ‐ one

82633 ‐ 79 ‐ 2

Not allowed 23

Harmonized classification: R43/H317 25

Not allowed

Methylchloroisothiazolinone (INCI) (5 ‐ chloro ‐ 2 ‐ methyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one)

26172 ‐ 55 ‐ 4

Not allowed 23

Preregistered for 2010, but not registered 28

Not classified

Not allowed

Methylchloroisothiazolinone (INCI) (5 ‐ chloro ‐ 2 ‐ methyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one) and methylisothiazolinone (INCI) (2 ‐ methyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one)

55965 ‐ 84 ‐ 9 and 96118 ‐ 96 ‐ 6

Allowed at 15 ppm (3:1) 29,23

Preregistered for 2010, but not registered

Harmonized classification: R43/H317 with specific concentration limit: 15 ppm 25

RoI France, concerning environmental classification: by end of 2014 30

First product:

Review programme: PT 2, 4, 6, 11, 12, and 13 26

Non ‐ included: PT 3, 7, 9, and 10 27

Second product: not allowed

Methylisothiazolinone (INCI) (2 ‐ methyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one)

2682 ‐ 20 ‐ 4

Allowed at 100 ppm 23,31

Preregistered for 2010, but not registered 28

Harmonized classification: R43/H317 with non ‐ specific concentration limit

Inventory (self ‐ classification): R43/H317 with specific concentration limit: 0.1%

Slovenia by end of 2013 32

Review programme: PT 2, 6, 11, 12, and 13 26

Non ‐ included: PT 4, 7, 9, 10, and 22 27

Octylisothiazolinone (INCI) (2 ‐ n ‐ octyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one)

26530 ‐ 20 ‐ 1

Not allowed 23

Preregistered for 2010, but not registered 28

Harmonized classification: R43/H317 with specific concentration limit: 0.05% 25

Review programme: PT 6, 7, 9, 10, 11, and 13 26

Non ‐ included: PT 4, 8, and 12 27

1 BPR, biocidal products regulation; CLP, the regulation on classification, labelling and packaging of substances and mixtures; INCI, International Nomenclature of Cosmetic Ingredients; PT, product type; REACH, Registration, Evaluation, Authorization and Restriction of Chemical substances; RoI, registry of intention – ‘warning’ of future proposal.

  • 2 * According to CLP there is non ‐ specific concentration limit for MI but according to the inventory there is a “self ‐ classification” with a specific concentration limit on 0.1%. This concentration is not validated or authorized but is used by some manufactures because of the allergenic potency of MI. For those manufacturer this concentration will be effective from 1st of June 2015.
  • 3 ** The European Commission requested Slovenia to classify MI according to the Annex XV dossier in REACH. The deadline was December 2013.

In view of the above, we provide an overview of the occurrence of isothiazolinones in registered chemical products, and discuss the clinical and general health implications.

Methods Identification of allergens

We selected the isothiazolinones listed in the Dictionary of Contact Allergens: Chemical Structures, Sources, and References from Kanerva's Occupational Dermatitis[33] .

In the examination of product types registered with content of the isothiazolinones, the chemical names and the Chemical Abstract Service (CAS) numbers for these isothiazolinones were searched for in the Danish Product Register Database (PROBAS) (September 2012).

The Danish Product Register Database

PROBAS is a database in which the composition of, primarily, hazardous chemical products for occupational use is registered. Products are registered: (i) if the product/substance is manufactured or imported for occupational use in a quantity of > 100 kg annually; (ii) if the product contains at least one chemical that is registered as harmful according to the Danish Ministry of the Environment and the Danish Working Environment Authority (WEA); (iii) if the product contains ≥ 1% of the substance (for preservatives, the limit is 0.1%); (iv) if the product/substance is assigned an occupational exposure limit in the WEA list of limit values for substances and materials; and/or (v) if materials contain ≥ 1% of a substance that has been assigned an occupational exposure limit in the WEA list of limit values for substances and materials [34] . When a product is registered in PROBAS, we assume that it is used in the Danish work environment.

PROBAS is updated at the end of every odd year with data collected from the manufacturers in even years. In cases where there were fewer than three manufacturers, the specific product types were classified as confidential.

In PROBAS, the chemicals are categorized according to the Use Categories Nordic (UCN) code system [35] . The system is the same in Norway, Sweden, and Denmark. The system consists of main groups and subgroups. The code for the main group consists of three characters, and the code for the subgroup consists of the main group plus three digits. One chemical can have more than one UCN code. According to the principal manufacturer of MCI/MI, MCI is not sold as an independent substance, so, even though it is listed on its own in PROBAS, it is likely to be used together with MI.

All confidential information was omitted from the dataset. No main groups were deleted, but subgroups that had a ratio of < 2% between the main group and the subgroup were deleted by the authors to maintain a more relevant overview.

Results

The isothiazolinones included in this study are shown in Table [NaN] . All seven isothiazolinones were registered in PROBAS. The results of the search in the database for different types of registered product are shown in Tables [NaN] and [NaN] . The concentrations listed in the two tables are in the same format as used in PROBAS. It is not possible to compare the different product types, because some of them are raw materials and others are products for the downstream user.

The results from the Danish Product Register Database (PROBAS) for benzisothiazolinone, methylisothiazolinone, methylchloroisothiazolinone, and Methylchloroisothiazolinone/ methylisothiazolinone

Main groupNo. of products in groupBenzisothiazolinone; CAS no. 2634 ‐ 33 ‐ 5Methylisothiazolinone; CAS no. 2682 ‐ 20 ‐ 4Methylchloroisothiazolinone; CAS no. 26172 ‐ 55 ‐ 4Methylchloroisothiazolinone/methylisothiazolinone; CAS no. 55965 ‐ 84 ‐ 9
No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)
Absorbents and adsorbents9033.3750.136966.740.02147
Air cleaners and anti ‐ odour agents4566.740.02147
Biocides1174262.20.04455.5342.90.05101.1252.10.1117.20.9272.30.0314.11.6
Car care products962121.92.55.40.261818.820.00833.5
Binding agents366205.50.60.1201215.70.40.13818251.40.90.0121.4195.24.710.0123.3
Binding agents for paints, adhesives, etc.184154.10.60.1254143.880.138282102.7110.0124.2
Other binding agents16841.10.90.0121.382.24.710.00421.7
Softeners5958.5120.0133.8
Other softeners3246.8120.0138.8
Colouring agents324257.712.514863611.10.250.0556.4226.80.750.0138.872.21.40.01529.2
Pigments for paints and printing inks191164.912.50.1265257.71.40.0150.5175.24.20.0146.141.21.40.0018.7
Other colouring agents12582.514.710.13103.10.250.0583.2
Flooring materials14664.193.90.0519953.47.50.05137
Impregnation/proofing12275.710.50.0312686.61.360.01322.143.30.010.003710.0
Cosmetics48491.90.750.08517481.70.010.0034.9
Construction materials20131.55000.290.13
Adhesives752283.70.230.10173172.30.50.02347.660.80.960.0037.6243.20.090.0530.9
Paint and varnish356754415.30.010.3317647113.20.010.08536.32757.70.010.0712.936310.20.013.9103
Paint: water ‐ based, decorative/protection, industrial use2191444.00.010.051961103.10.010.02420.3752.10.040.0011.51052.90.020.02225.4
Paint and varnishes: additives7767.80.550.0311879.10.860.01865.9
Metal surface treatment remedies46840.9400.2816
Solvents79740.510.125140.530.1254
Surface active agents517163.10.10.0473.2163.10.530.0136.061.20.980.0016.051.02.70.0017.6
Surface treatment for paper, cardboard, and other non ‐ metals10632.80.150.0256.443.81.350.01247.832.83.60.0137.387.520.02331.3
Surface treatment for paper and cardboard7365.720.02338.1
Polishing agents3506518.60.660.0476.96017.10.250.02431.3205.70.150.9433329.10.081345
Polishing agents for lacquers (car wax)93185.10.780.0257.4226.31.40.02460.172.04.20.07281
Wax and other polishing preparations for floors81277.70.660.0251.3246.90.250.0099.41102.90.390.0015.4185.10.080.04841.8
Other polishing agents7192.635.40.04194
Cleaning/washing agents35601083.00.060.1783.4872.40.020.1955.8341.00.030.6156501.40.040.9363
Cracking indicators5623.60.750.004530.3
Rust inhibitors421112.60.70.0690.7122.90.010.0648.830.70.040.0013.4
Corrosion inhibitors169102.40.70.0693.0
Raw materials and intermediate products57230.7750.0191.7
Rinsing agents951111.61600.126333.21.80.00043.5666.32.30.0016.1
Rinsing agents (for dishwashing machines)5033.21.80.00043.5633.25.30.0019.9
Lubricants122530.20.210.0212750.42.80.071173
Toners561017.926.40.05271610.73.90.04998.347.11.070.00110.8
Printing inks293103.480.13413144.82.40.0762.1124.17.40.0765.6134.410.43834
Filling agents956161.75.40.17206181.90.280.178.8131.40.760.534380.80.140.0027.5
Viscosity changers7134.29.90.00530.0
Total9850.01458840.01104740.0117.26110.0114.1

4 * Percentages.

The results from the D anish P roduct R egister D atabase (PROBAS) for dichlorooctylisothiazolinone and octylisothiazolinone

Main groupNo. of products in groupDichlorooctylisothiazolinone; CAS no. 64359 ‐ 81 ‐ 5Octylisothiazolinone; CAS no. 26530 ‐ 20 ‐ 1
No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)No. of products% of main groupConcentration (minimum) (ppm)Concentration (maximum) (%)Mean (ppm)
Biocides11741210.1128.111.1161.47.1161.7
Binding agents36620.5100.0271.2
Cooling agents for metal processing20131.51000.03177
Adhesives75240.567.516.34.1
Paint and varnish3567381.14050.20.11601.70.020.1177
Filling agents95650.5940.136850.5250.50.13
Total589428.11110.0216.3

5 * Percentages.

Benzisothiazolinone (BIT) (CAS no. 2634 ‐ 33 ‐ 5)

BIT was registered in 985 different products registered in PROBAS, and was the isothiazolinone most often found in products registered in PROBAS. The top three product types containing BIT were paints and varnishes (544), cleaning/washing agents (108), and polishing agents (65). BIT was registered in concentrations from 0.01 ppm to 45%.

Methylisothiazolinone (CAS no. 2682 ‐ 20 ‐ 4)

MI was the second most frequently registered isothiazolinone, with 884 different products registered in PROBAS. The top three product types containing MI were paints and varnishes (471), cleaning/washing agents (87), and polishing agents (60). MI was registered in concentrations from 0.01 ppm to 10%.

Methylchloroisothiazolinone/methylisothiazolinone (CAS no. 55965 ‐ 84 ‐ 9)

MCI/MI was the third most frequently registered isothiazolinone, with 611 different products registered in PROBAS. The top three product types containing MCI/MI were paints and varnishes (363), cleaning/washing agents (50), and polishing agents (32). MCI/MI was registered in concentrations from 0.01 ppm to 14%.

Methylchloroisothiazolinone (CAS no. 26172 ‐ 55 ‐ 4)

MCI was the fourth most frequently registered isothiazolinone, with 474 different products registered in PROBAS. The top three product types containing MCI were paints and varnishes (275), cleaning/washing agents (34), and biocides (25). MCI was registered in concentrations from 0.01 ppm to 17%.

Octylisothiazolinone (OIT) (CAS no. 26530 ‐ 20 ‐ 1)

OIT was the fifth most frequently registered isothiazolinone, with 111 different products registered in PROBAS. The top three product types containing OIT were paints and varnishes (60), biocides (16), and filling agents (5). OIT was registered in concentrations from 0.02 ppm to 16.3%.

Dichlorooctylisothiazolinone (DCOIT) (CAS no. 64359 ‐ 81 ‐ 5)

DCOIT was registered in 58 different products, which was the second lowest number among the isothiazolinones in this study. The top three product types containing DCOIT were paints and varnishes (38), biocides (12), and filling agents (5). DCOIT was registered in concentrations from 94 ppm to 28.1%.

2 ‐ Methyl ‐ 4,5 ‐ trimethylene ‐ 4 ‐ isothiazolin ...

MTMIT was the only isothiazolinone for which all of the use categories (UCN codes) were confidential. The chemical was registered in seven products in concentrations from 47.6 to 150 ppm.

Discussion

The present study shows that thousands of products are registered in PROBAS as containing isothiazolinones.

BIT and MI were registered in 985 and 884 products, respectively; MCI/MI was registered in 611 products.

The most prominent product type containing these three isothiazolinones was paints and varnishes (with a total of 3567 products), in which BIT, MI and MCI/MI were the predominant isothiazolinones. This is in accordance with clinical experience (Table [NaN] ), where isothiazolinone allergies have been reported in painters [36] ,[37] ,[38] ,[39] and paint production workers [12] ,[40] ,[41] . It is also known that MCI/MI and MI may evaporate and cause airborne allergic contact dermatitis, a manifestation that has been increasingly seen with particular MI ‐ preserved paints [36] ,[37] ,[38] ,[42] . MI and BIT have been found to cause airborne contact dermatitis, respiratory symptoms, including acute asthma, and systemic allergic contact dermatitis [15] ,[36] . The presence of MI in paints was further highlighted in a study in which, of 19 different water ‐ based paints from the Danish retail marked, all contained MI, four contained MCI, and 16 contained BIT [43] . The emission of BIT, MCI and MI from paint has also been shown [43] .

Clinical effects of cutaneous and airborne exposures to the isothiazolinone preservatives

Exposures

Concentrations

Clinical symptoms

Duration of eczema/consequence

Reference

Cosmetic products

MCI/MI < 15 ppm

MI < 100 ppm

Allergic contact dermatitis: face and hands

One event: 4–6 months

Repeated events: chronic disease

18,19,20,21

Paint, glues, oils, etc.

MCI/MI < 14 ppm

MI < 300 ppm

BIT < 360 ppm 43

Severe allergic contact dermatitis: face and hands

Airborne dermatitis, respiratory symptoms

6–12 months

Change or loss of job

11,12,13,14,36,37,38,42,44,45,46

Biocides

MCI > 0.5%

MI > 0.5%

BIT > 0.5%

Chemical burns, generalized severe allergic contact dermatitis with subjective symptoms

Systemic allergic dermatitis, respiratory symptoms

Chronic disease, risk of disability

11,15,45

Airborne exposure

Probably < 60 mg/m243

Primary sensitization may be possible

Flare ‐ ups of facial and systemic allergic dermatitis

Acute and chronic disease

15,36,37,38,42,43,47

6 BIT, benzisothiazolinone; MCI, methylchloroisothiazolinone; MI, methylisothiazolinone.

Preservative exposure from paints has changed since 2000, when MI was introduced as a stand ‐ alone preservative and, to some extent, replaced MCI/MI. The reason may be that, whereas MCI/MI is on the list of dangerous substances, labelled R43/H317 (may cause sensitization), and has to be declared on the label if it is present in amounts > 15 ppm, no such requirements exist for MI (Table [NaN] ); instead, there is self ‐ classification, with a specific concentration limit of 0.1% in industrial products [25] . This may erroneously lead the manufacturers to assume that MI is unproblematic [29] .

The products registered with the highest content of isothiazolinones were car care products, BIT being present in 21.9% of products, and MI in 18.8%; a similar pattern was seen for polishing agents for cars and floor products (Tables [NaN] and [NaN] ). We have not found any reports concerning contact allergy related to the use of such products.

Contact allergy to isothiazolinones in the paper and textile industry has also been reported [14] ,[17] ,[48] ,[49] . In our study, BIT, MI and MCI/MI were registered in products for the surface treatment of paper, cardboard, and other non ‐ metals, although not very frequently. In the paper industry, they may be present in the concentrated biocides that are used and added to the pulp. All of the isothiazolinones were registered as biocide products. This is a product group that may have multiple uses.

Contact allergy to BIT and OIT has been reported in metalworkers [50] ; these are also the two allergens found in cooling agents by chemical analysis in a Finnish study [51] . In PROBAS, only OIT was registered in cooling agents for metal processing (Table [NaN] ). This emphasizes the importance of patch testing with these special isothiazolinones in metalworkers with occupational eczema.

Exposure to high concentrations of isothiazolinones (Table [NaN] ) can cause chemical burns followed by contact sensitization resulting from a single exposure [52] ,[53] ,[54] ,[55] ,[56] ,[57] . Further accidental exposure to such high concentrations may lead to generalized dermatitis accompanied by systemic contact dermatitis and subjective symptoms [15] . Such cases may develop into chronic diseases.

A part of the problem is that much emphasis and reliance has been put on the results of animal assays, in particular the LLNA, to predict the sensitization potency of these substances. The reporting of these results is very brief in the scientific literature, as EC3 values only, not supported by data, and has also been shown to be misleading [9] . This is in contrast to the amount of human data from the occupational setting and consumers, which, for a long period of time, have been ignored by industry and regulators.

In three product categories, namely paints and varnishes, biocides, and filling agents, all six isothiazolinones were registered, whereas, for all other product categories, some but not all isothiazolinones were used.

There are only few studies on cross ‐ reactions between the different isothiazolinones. In 1992, Damstra et al. found, in an analysis of 556 patch tested patients, that 8 of 10 patients who reacted to BIT also reacted to MCI/MI, and 8 of 56 patients who reacted to MCI/MI also reacted to BIT [58] . In a recent study, Mose et al. found that all patients with concomitant positive patch test reactions to OIT, BIT and MCI/MI were painters, which suggests concomitant sensitization rather than cross ‐ reactivity [16] . Cross ‐ reactivity can only be studied in animals or if the primary sensitizer in humans is known. In GPMTs, it was shown that cross ‐ reactivity between MCI and MI exists, whereas no cross ‐ reactivity could be shown between MCI, MI as primary sensitizer, and OIT, and probably BIT [59] . In 2008, Isaksson et al. also showed, by testing workers accidentally sensitized to MCI, that cross ‐ reactivity between MCI and MI is likely, depending on the degree of contact allergy [60] , which is in accordance with clinical experience [61] . This means that, in detecting cases of contact allergy to isothiazolinones, one cannot rely on testing only with MCI and MI in the baseline series.

It is very important for the physician and the clinical procedure that all information concerning the product be on the product label and/or in the Material Safety Data Sheet (MSDS) or other product datasheets, so that exposures to allergens can be identified, appropriate patch testing performed, and the correct diagnosis made. Otherwise, important allergens can be missed. The correct diagnosis is very important for patients with occupational allergic contact dermatitis, both for the medical prognosis and for the compensation, depending on national laws [62] .

In conclusion, isothiazolinones are present in multiple products registered for use at the workplace, and may occur in high concentrations. BIT was the most frequent isothiazolinone, being registered in the most products (985), and the concentration range was 0.01 ppm to 45%.

Knowledge of the use and exposure to the isothiazolinone preservatives, together with the contact allergic potential and the clinical disease related to the exposure, leads to the following points to be addressed:

The use concentrations in the different exposure scenarios need to be revised.

All types of isothiazolinone, independently of concentration, should be labelled on the product and included in the MSDS.

The use of concentrated solutions of isothiazolinones should only be permitted in closed systems, and the workers involved need proper education.

Is the margin of safety for isothiazolinones so low that future use should be abolished?

Acknowledgements

We thank the Danish Working Environment Research Fund for funding this project, and give special thanks to Peter Herskind (chief consultant in the work environment at the Confederation of Danish Industry) and Jan Toft Rasmussen (consultant at the Danish Metalworkers' Union) for participating in the steering group and for valuable help throughout the project, to Lea Stine Tobiassen (toxicologist at the Danish Environmental Protection Agency) for valuable help throughout the project, and to Poul Erik Andersen at the Danish Product Register for performing the analysis in PROBAS.

Footnotes 1 Conflicts of interest: The authors declare no conflict of interests. 2 Funding sources: Funding from the Danish Working Environment Research Fund (project no: 21 ‐ 2009 ‐ 09). References Thyssen J P, Johansen J D, Menné T. Contact allergy epidemics and their controls. Contact Dermatitis 2007 : 56 : 185 – 195. Basketter D A, Rodford R, Kimber I, Smith I, Wahlberg J E. Skin sensitization risk assessment: a comparative evaluation of 3 isothiazolinone biocides. Contact Dermatitis 1999 : 40 : 150 – 154. 3 Flyvholm M ‐ A. Preservatives in registered chemical products. Contact Dermatitis 2005 : 53 : 27 – 32. 4 Loveless S E, Api A M, Crevel R W et al. Potency values from the local lymph node assay: application to classification, labelling and risk assessment. Regul Toxicol Pharmacol 2010 : 56 : 54 – 66. 5 Magnusson B, Kligman A M. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 1969 : 52 : 268 – 276. 6 Thyssen J P, Gimenez ‐ Arnau E, Lepoittevin J P, Menné T, Boman A, Schnuch A. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II. Contact Dermatitis 2012 : 66 (Suppl. 1): 25 – 52. 7 Thyssen J P, Gimenez ‐ Arnau E, Lepoittevin J P, Menné T, Boman A, Schnuch A. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part III. Contact Dermatitis 2012 : 66 (Suppl. 1): 53 – 70. 8 Gerberick G F, Sikorski E E. In vitro and in vivo testing techniques for allergic contact dermatitis. Am J Contact Dermat 1998 : 9 : 111 – 118. 9 Roberts D W. Methylisothiazolinone is categorised as a strong sensitiser in the Murine Local Lymph Node Assay. Contact Dermatitis 2013 : 69 : 261 – 262. 10 Thyssen J P, Gimenez ‐ Arnau E, Lepoittevin J P, Menné T, Boman A, Schnuch A. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part I. Contact Dermatitis 2012 : 66 (Suppl. 1): 11 – 24. 11 Bregnbak D, Lundov M D, Zachariae C, Menné T, Johansen J D. Five cases of severe chronic dermatitis caused by isothiazolinones. Contact Dermatitis 2013 : 69 : 57 – 59. 12 Mathias C G, Andersen K E, Hamann K. Allergic contact dermatitis from 2 ‐ n ‐ octyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one, a paint mildewcide. Contact Dermatitis 1983 : 9 : 507 – 509. 13 Alto ‐ Korte K, Alanko K, Henriks ‐ Eckerman M L, Kuuliala O, Jolanki R. Occupational allergic contact dermatitis from 2 ‐ N ‐ octyl ‐ 4 ‐ isothiazolin ‐ 3 ‐ one. Contact Dermatitis 2007 : 56 : 160 – 163. 14 Kawai K, Nakagawa M, Sasaki Y, Kawai K. Occupational contact dermatitis from Kathon 930. Contact Dermatitis 1993 : 28 : 117 – 118. 15 Kaur ‐ Knudsen D, Menné T, Christina C B. Systemic allergic dermatitis following airborne exposure to 1,2 ‐ benzisothiazolin ‐ 3 ‐ one. Contact Dermatitis 2012 : 67 310 – 312. 16 Mose A P, Frost S, Ohlund U, Andersen K E. Allergic contact dermatitis from octylisothiazolinone. Contact Dermatitis 2013 : 69 : 49 – 52. 17 Burden A D, O'Driscoll J B, Page F C, Beck M H. Contact hypersensitivity to a new isothiazolinone. Contact Dermatitis 1994 : 30 : 179 – 180. 18 Lundov M D, Opstrup M S, Johansen J D. Methylisothiazolinone contact allergy – growing epidemic. Contact Dermatitis 2013 : 69 : 271 – 275. 19 Lundov M D, Zachariae C, Menné T, Johansen J D. Airborne exposure to preservative methylisothiazolinone causes severe allergic reactions. BMJ 2012 : 345 : e8221. 20 Uter W, Geier J, Bauer A, Schnuch A. Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis 2013 : 69 : 231 – 238. 21 Uter W, Gefeller O, Geier J, Schnuch A. Methylchloroisothiazolinone/methylisothiazolinone contact sensitization: diverging trends in subgroups of IVDK patients in a period of 19 years. Contact Dermatitis 2012 : 67 : 125 – 129. 22 Scientific Committee on Consumer Safety. Opinion on Benzisothiazolinone : European Commission Health & Consumers, June 26, 2012. Available at: http://ec.europa.eu/health/scientific%5fcommittees/consumer%5fsafety/docs/sccs%5fo%5f099.pdf (last accessed 2 January 2014). 23 The European Parliament and the Council of the European Union. Regulation (EC) No. 1223/2009 of the European Parliament and on the Council of 30 November 2009 on cosmetic products, 30 November 2009. Available at: http://eur ‐ lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:EN:PDF (last accessed 2 January 2014). 24 ECHA. Intentions – Substances identified for 2013 registration, 27 May 2013. Available at: http://echa.europa.eu/documents/10162/13632/intentions%5f2013%5fen.pdf (last accessed 2 January 2014). 25 ECHA. Regulation on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No. 1907/2006, the European Parliament and the Council of the European Union, 29 October 2010. Available at: http://eur ‐ lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:353:0001:1355:EN:PDF (last accessed 2 January 2014). 26 The Commission of the European Communities. Commission regulation – on the second phase of the 10 ‐ year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, 4 December 2007. 27 ECHA. Biocides: non ‐ inclusion decisions, 8 December 2013. Available at: https://circabc.europa.eu/d/a/workspace/SpacesStore/491962c1 ‐ 8f3e ‐ 4adb ‐ 9e0c ‐ cf1a782895d9/Consolidated%20list%20of%20non ‐ inclusion%20decisions.pdf (last accessed 2 January 2014). 28 ECHA. List of pre ‐ registered substances, 8 December 2013. Available at: http://apps.echa.europa.eu/preregistered/attachments/prs%5fcomplete%5f20090327.csv (last accessed 2 January 2014). 29 Scientific Committee on Consumer Safety. Opinion on the mixture of 5 ‐ chloro ‐ 2 ‐ methylisothiazolin ‐ 3(2H) ‐ one and 2 ‐ methylisothiazolin ‐ 3(2H) ‐ one, Colipa no. P56. 8 December 2009. Available at: http://ec.europa.eu/health/scientific%5fcommittees/consumer%5fsafety/docs/sccs%5fo%5f009.pdf (last accessed 2 January 2014). 30 ECHA. Registry of current Harmonised Classification and Labelling intentions – Methylisothiazolinone: Methylchloroisothiazolinone (1:3), 9 March 2012. Available at: http://echa.europa.eu/registry ‐ current ‐ classification ‐ and ‐ labelling ‐ intentions/ ‐ /substance/1301/search/+/del/20/col/NOTIFICATIONDATEROI_C/type/desc/pre/2/view (last accessed 2 January 2014). 31 The Scientific Committee on Cosmetic Products and Non ‐ Food Products Intended for Consumers. 2004. Opinion on methylisothiazolinone, Colipa no. P94. 23 April 2004. Available at: http://ec.europa.eu/health/ph%5frisk/committees/sccp/documents/out270%5fen.pdf (last accessed 2 January 2014). 32 ECHA. Registry of current Harmonised Classification and Labelling intentions – Methylisothiazolinone, 23 November 2013. Available at: http://echa.europa.eu/registry ‐ current ‐ classification ‐ and ‐ labelling ‐ intentions/ ‐ /substance/2816/search/+/term (last accessed 2 January 2014). 33 Lepoittevin J ‐ P, Le Coz C J. Dictionary of contact allergens: chemical structures, sources, and references. In: Kanerva's Occupational Dermatology, 2nd edition, Rustemeyer T, Elsner P, John S M, Maibach H (eds): Berlin, Heidelberg, Springer ‐ Verlag, 2012 : pp. 1737 – 1848. 34 Danish Working Environment Authority. Substances and materials that must be notified to the Product Registry, 0000. Available at: http://arbejdstilsynet.dk/en/engelsk/produktregistret/produkter ‐ der ‐ skal ‐ anmeldes.aspx (last accessed 17 December 2013). 35 Substances in Products in the Nordic Countries. Substances in products in the Nordic Countries, Use Categories Nordic (UCN), 12 September 2007. 36 Lundov M D, Mosbech H, Thyssen J P, Menné T, Zachariae C. Two cases of airborne allergic contact dermatitis caused by methylisothiazolinone in paint. Contact Dermatitis 2011 : 65 : 176 – 179. 37 Schubert H. Airborne contact dermatitis due to methylchloro ‐ and methylisothiazolinone (MCI/MI). Contact Dermatitis 1997 : 36 : 274. 38 Kaae J, Menné T, Thyssen J P. Presumed primary contact sensitization to methylisothiazolinone from paint: a chemical that became airborne. Contact Dermatitis 2012 : 66 : 341 – 342. 39 Fischer T, Bohlin S, Edling C, Rystedt I, Wieslander G. Skin disease and contact sensitivity in house painters using water ‐ based paints, glues and putties. Contact Dermatitis 1995 : 32 : 39 – 45. 40 Gruvberger B, Bruze M, Almgren G. Occupational dermatoses in a plant producing binders for paints and glues. Contact Dermatitis 1998 : 38 : 71 – 77. 41 Thyssen J P, Sederberg ‐ Olsen N, Thomsen J F, Menné T. Contact dermatitis from methylisothiazolinone in a paint factory. Contact Dermatitis 2006 : 54 : 322 – 324. 42 Lundov M D, Menné T. Airborne exposure to methylchloroisothiazolinone and methylisothiazolinone from a toilet cleaner. Contact Dermatitis 2013 : 68 : 252 – 253. 43 Lundov M D, Kolarik B, Bossi R, Gunnarsen L, Johansen J. Emission of isothiazolinones from water ‐ based paint, 2013 (in preparation). 44 Aalto ‐ Korte K, Ackermann L, Henriks ‐ Eckerman M L, Valimaa J, Reinikka ‐ Railo H, Leppanen E, Jolanki R. 1,2 ‐ benzisothiazolin ‐ 3 ‐ one in disposable polyvinyl chloride gloves for medical use. Contact Dermatitis 2007 : 57 : 365 – 370. 45 Friis U F, Menné T, Thyssen J P, Johansen J D. A patient's drawing helped the physician to make the correct diagnosis: occupational contact allergy to isothiazolinone. Contact Dermatitis 2012 : 67 : 174 – 176. 46 Uter W, Uter M, Steen ‐ Schuberth B, Schnuch A. Allergic contact dermatitis caused by methylisothiazolinone from a ‘waist reduction belt’. Contact Dermatitis 2012 : 66 : 347 – 348. 47 Aerts O, Cattaert N, Lambert J, Goossens A. Airborne and systemic dermatitis, mimicking atopic dermatitis, caused by methylisothiazolinone in a young child. Contact Dermatitis 2013 : 68 : 250 – 251. 48 Podmore P. An epidemic of isothiazolinone sensitization in a flax spinning mill. Contact Dermatitis 1998 : 38 : 165 – 166. 49 Estlander T, Jolanki R, Kanerva L. Occupational allergic contact dermatitis from 2,3 ‐ epoxypropyl trimethyl ammonium chloride (EPTMAC) and Kathon LX in a starch modification factory. Contact Dermatitis 1997 : 36 : 191 – 194. 50 Geier J, Lessmann H, Dickel H et al. Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). Contact Dermatitis 2004 : 51 : 118 – 130. 51 Henriks ‐ Eckerman M L, Suuronen K, Jolanki R. Analysis of allergens in metalworking fluids 1. Contact Dermatitis 2008 : 59 : 261 – 267. 52 Bayraktar A, Ozcan M. An unusual case: burn following an accidental exposure to methylchloroisothiazolinone/methylisothiazolinone. J Burn Care Res 2007 : 28 : 195 – 197. 53 Monsalvez V, Fuertes L, Frutos J O, Vanaclocha F. Sensitization to methylchloroisothiazolinone–methylisothiazolinone after a burn caused by massive accidental occupational exposure. Actas Dermosifiliogr 2011 : 102 : 224 – 226. 54 Bruze M, Dahlquist I, Gruvberger B. Chemical burns and allergic contact dermatitis due to Kathon WT. Am J Contact Dermatitis 1990 : 1 : 91 – 93. 55 O'Driscoll J B, Beck M H. Occupational allergic contact dermatitis from Kathon WT. Contact Dermatitis 1988 : 19 : 63. 56 Kujala V, Niinimaki A. Occupational induction of hypersensitivity after an accidental exposure to chloromethylisothiazolinone and methylisothiazolinone (CMI/MI) in an industrial worker. Occup Med (Lond) 1999 : 49 : 51 – 53. 57 Ng C K, Tay P. Two case reports of delayed skin burns from methylisothiazolines used in water treatment. Singapore Med J 1996 : 37 : 577 – 578. 58 Damstra R J, van Vlotten W A, van Ginkel C J. Allergic contact dermatitis from the preservative 1,2 ‐ benzisothiazolin ‐ 3 ‐ one (1,2 ‐ BIT; Proxel): a case report, its prevalence in those occupationally at risk and in the general dermatological population, and its relationship to allergy to its analogue Kathon CG. Contact Dermatitis 1992 : 27 : 105 – 109. 59 Bruze M, Fregert S, Gruvberger B, Persson K. Contact allergy to the active ingredients of Kathon CG in the guinea pig. Acta Derm Venereol 1987 : 67 : 315 – 320. 60 Isaksson M, Bruze M, Gruvberger B. Cross ‐ reactivity between methylchloroisothiazolinone/methylisothiazolinone, methylisothiazolinone, and other isothiazolinones in workers at a plant producing binders for paints and glues. Contact Dermatitis 2008 : 58 : 60 – 62. 61 Schnuch A, Lessmann H, Geier J, Uter W. Contact allergy to preservatives. Analysis of IVDK data 1996–2009. Br J Dermatol 2011 : 164 : 1316 – 1325. 62 Frosch P J, Aberer W, Agner T et al. International comparison of legal aspects of workers' compensation for occupational contact dermatitis. In: Contact Dermatitis, 5th edition : Berlin, Heidelberg, Springer ‐ Verlag, 2010 : pp. 1029 – 1051.

By Ulrik Fischer Friis; Torkil Menné; Mari ‐ Ann Flyvholm; Jens Peter Ellekilde Bonde; Jean ‐ Pierre Lepoittevin; Christophe J. Le Coz and Jeanne Duus Johansen

Titel:
Isothiazolinones in commercial products at Danish workplaces
Autor/in / Beteiligte Person: FRIIS, Ulrik Fischer ; MENNE, Torkil ; FLYVHOLM, Mari-Ann ; ELLEKILDE BONDE, Jens Peter ; LEPOITTEVIN, Jean-Pierre ; LE COZ, Christophe J ; JOHANSEN, Jeanne Duus
Link:
Zeitschrift: Contact dermatitis, Jg. 71 (2014), Heft 2, S. 65-74
Veröffentlichung: Oxford: Blackwell, 2014
Medientyp: academicJournal
Umfang: print, 62 ref
ISSN: 0105-1873 (print)
Schlagwort:
  • Europe
  • Europa
  • Danemark
  • Denmark
  • Dinamarca
  • Dermatology
  • Dermatologie
  • Immunology, immunopathology, allergology
  • Immunologie, immunopathologie, allergologie
  • Sciences biologiques et medicales
  • Biological and medical sciences
  • Sciences medicales
  • Medical sciences
  • Immunopathologie
  • Immunopathology
  • Maladies allergiques
  • Allergic diseases
  • Dermatoses allergiques. Allergie aux piqûres d'insectes
  • Skin allergic diseases. Stinging insect allergies
  • Sante publique. Hygiene-medecine du travail
  • Public health. Hygiene-occupational medicine
  • Médecine du travail
  • Occupational medicine
  • Inmunopatología
  • Pathologie de la peau
  • Skin disease
  • Piel patología
  • Allergie
  • Allergy
  • Alergia
  • Dermatite de contact
  • Contact dermatitis
  • Dermatitis de contacto
  • Forme commerciale
  • Commercial form
  • Forma comercial
  • Lieu travail
  • Work place
  • Lugar trabajo
  • Isothiazol-3-one(2,3-dihydro-2-méthyl)
  • Isothiazol-3-one(5-chloro-2,3-dihydro-2-méthyl)
  • Isothiazolinone dérivé
  • 2-methyl-4,5-trimethylene-4-isothiazolin-3-one
  • allergic contact dermatitis
  • benzisothiazolinone
  • dichlorooctylisothiazolinone
  • isothiazolinones
  • methylchloroisothiazolinone
  • methylisothiazolinone
  • octylisothiazolinone
  • Subject Geographic: Europe Europa Danemark Denmark Dinamarca
Sonstiges:
  • Nachgewiesen in: PASCAL Archive
  • Sprachen: English
  • Original Material: INIST-CNRS
  • Document Type: Article
  • File Description: text
  • Language: English
  • Author Affiliations: Department of Dermato-Allergology, National Allergy Research Centre, Copenhagen University Hospital Gentofte, 2900 Hellerup, Denmark ; Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, 2900 Hellerup, Denmark ; The National Research Centre for the Working Environment, 2100 Copenhagen, Denmark ; Department of Occupational and Environmental Medicine, Copenhagen University Hospital Bispebjerg, 2400 Copenhagen, Denmark ; Laboratoire de Dermatochimie, University of Strasbourg, 67081 Strasbourg, France ; Cabinet de Dermatologie, Laboratoire de Dermatochimie, 67081 Strasbourg, France
  • Rights: Copyright 2015 INIST-CNRS ; CC BY 4.0 ; Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
  • Notes: Immunopathology ; Public health. Hygiene-occupational medicine. Information processing

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -